Elevated levels of myostatin, a negative regulator of muscle growth, may contribute to muscle wasting or rheumatoid cachexia (RC).6,7 A deeper understanding of the pathophysiology of RA is essential for developing effective treatments that can mitigate musculoskeletal decline and enhance patient outcomes. Here, MSTN is linked to rheumatoid arthritis.